Eli Lilly's one-year average price target was raised to CHF 997.26 per share from CHF 801.57, a 24.41% increase versus the November 16, 2025 estimate. The update reflects improved analyst expectations for the stock's fundamental outlook. Impact is likely limited to sentiment and valuation rather than immediate price action.
Eli Lilly's one-year average price target was raised to CHF 997.26 per share from CHF 801.57, a 24.41% increase versus the November 16, 2025 estimate. The update reflects improved analyst expectations for the stock's fundamental outlook. Impact is likely limited to sentiment and valuation rather than immediate price action.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.18
